Li Zhiyu, Xu Hongyang
Department of Critical Care Medicine, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China.
Front Endocrinol (Lausanne). 2025 Feb 28;16:1509752. doi: 10.3389/fendo.2025.1509752. eCollection 2025.
Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) represents an essential lipid index and is closely related to the occurrence and development of diabetes and cardiovascular diseases (CVDs). Therefore, this study is intended to further investigate the association between the NHHR index and the mortality rate of CVDs in patients with type 2 diabetes mellitus (T2DM) and diabetic kidney disease (DKD).
The research sample was selected from the NHANES (National Health and Nutrition Examination Survey) database, and 5136 individuals were categorized based on quartiles of the NHHR index. Restricted cubic plots and COX regression models were utilized to examine the thresholds and patterns of the NHHR index in relation to the risk of CVDs mortality among T2DM patients as well as those with DKD. Subgroup analyses and p-values were used to evaluate interactions between different variables.
The NHHR index shows a nonlinear association with cardiovascular mortality in two patient groups, following an L-shaped pattern. In individuals with T2DM, a lower NHHR index (<1.68) correlates with an increased risk of death, demonstrating a 72.8% reduction in mortality risk for each unit increase in NHHR below this threshold. Similarly, among patients with DKD, a lower NHHR index (<1.82) is associated with heightened cardiovascular mortality risk, indicating a 48.2% reduction in death risk for each unit increase in NHHR beneath the specified threshold. In patients diagnosed with T2DM, the third quartile of the NHHR index was significantly linked to reduced mortality risk; the association remained consistent even when additional variables were considered [Hazard Ratio (HR), 0.82; 95% Confidence Interval (CI) (0.69-0.97); P=0.019]. Among patients with DKD, cardiovascular mortality was notably higher in the third and fourth quartiles of the NHHR index [Quartile3 HR, 1.57; 95% CI (1.10-2.24), P=0.013; Quartile4 HR, 2.04; 95% CI (1.28-3.26), P=0.003].
The NHHR is below 1.68, and an increase in the NHHR index is associated with a reduced risk of CVD mortality in patients with T2DM. Similarly, when the NHHR falls below 1.82, an elevation in the NHHR index correlates with a decreased risk of CVD mortality in patients with DKD.
非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NHHR)是一项重要的血脂指标,与糖尿病和心血管疾病(CVD)的发生发展密切相关。因此,本研究旨在进一步探讨NHHR指标与2型糖尿病(T2DM)和糖尿病肾病(DKD)患者CVD死亡率之间的关联。
研究样本选自美国国家健康与营养检查调查(NHANES)数据库,根据NHHR指标的四分位数对5136名个体进行分类。采用受限立方图和COX回归模型,研究T2DM患者以及DKD患者中NHHR指标与CVD死亡风险相关的阈值和模式。采用亚组分析和p值评估不同变量之间的相互作用。
在两组患者中,NHHR指标与心血管死亡率呈非线性关联,呈L形模式。在T2DM患者中,较低的NHHR指标(<1.68)与死亡风险增加相关,表明在该阈值以下,NHHR每增加一个单位,死亡风险降低72.8%。同样,在DKD患者中,较低的NHHR指标(<1.82)与心血管死亡风险增加相关,表明在指定阈值以下,NHHR每增加一个单位,死亡风险降低48.2%。在确诊为T2DM的患者中,NHHR指标的第三个四分位数与降低的死亡风险显著相关;即使考虑其他变量,这种关联仍然一致[风险比(HR),0.82;95%置信区间(CI)(0.69 - 0.97);P = 0.019]。在DKD患者中,NHHR指标的第三个和第四个四分位数的心血管死亡率显著更高[四分位数3的HR,1.57;95% CI(1.10 - 2.24),P = 0.013;四分位数4的HR,2.04;95% CI(1.28 - 3.26),P = 0.003]。
对于T2DM患者,当NHHR低于1.68时,NHHR指标升高与CVD死亡风险降低相关。同样,对于DKD患者,当NHHR低于1.82时,NHHR指标升高与CVD死亡风险降低相关。